BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24204560)

  • 1. MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.
    Radhakrishnan P; Mohr AM; Grandgenett PM; Steele MM; Batra SK; Hollingsworth MA
    PLoS One; 2013; 8(10):e73356. PubMed ID: 24204560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
    Jonckheere N; Van Seuningen I
    J Transl Med; 2018 Sep; 16(1):259. PubMed ID: 30236127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.
    Dharmaraj N; Chapela PJ; Morgado M; Hawkins SM; Lessey BA; Young SL; Carson DD
    Hum Reprod; 2014 Aug; 29(8):1730-8. PubMed ID: 24939955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.
    Lee J; Lee J; Yun JH; Jeong DG; Kim JH
    Tumour Biol; 2016 Sep; 37(9):12193-12202. PubMed ID: 27230679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.
    Horn A; Chakraborty S; Dey P; Haridas D; Souchek J; Batra SK; Lele SM
    Arch Pathol Lab Med; 2013 Apr; 137(4):546-51. PubMed ID: 23544943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of membrane-associated mucins in limbal stem cell deficiency and after transplantation of cultivated limbal epithelium.
    Pauklin M; Kakkassery V; Steuhl KP; Meller D
    Curr Eye Res; 2009 Mar; 34(3):221-30. PubMed ID: 19274530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases.
    Coppin L; Benomar K; Corfiotti F; Cattan S; Renaud F; Lapere C; Leteurtre E; Vantyghem MC; Truant S; Pigny P
    Pancreatology; 2016; 16(1):115-20. PubMed ID: 26613889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4.
    Xu D; Liu S; Zhang L; Song L
    Biochem Biophys Res Commun; 2017 Apr; 485(2):556-562. PubMed ID: 27923652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathobiological implications of MUC16 expression in pancreatic cancer.
    Haridas D; Chakraborty S; Ponnusamy MP; Lakshmanan I; Rachagani S; Cruz E; Kumar S; Das S; Lele SM; Anderson JM; Wittel UA; Hollingsworth MA; Batra SK
    PLoS One; 2011; 6(10):e26839. PubMed ID: 22066010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
    Chauhan SC; Singh AP; Ruiz F; Johansson SL; Jain M; Smith LM; Moniaux N; Batra SK
    Mod Pathol; 2006 Oct; 19(10):1386-94. PubMed ID: 16880776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.
    Lahdaoui F; Delpu Y; Vincent A; Renaud F; Messager M; Duchêne B; Leteurtre E; Mariette C; Torrisani J; Jonckheere N; Van Seuningen I
    Oncogene; 2015 Feb; 34(6):780-8. PubMed ID: 24608432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of membrane-associated mucins in the human ocular surface epithelium.
    Hori Y; Spurr-Michaud S; Russo CL; Argüeso P; Gipson IK
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):114-22. PubMed ID: 14691162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16.
    Duraisamy S; Ramasamy S; Kharbanda S; Kufe D
    Gene; 2006 May; 373():28-34. PubMed ID: 16500040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.
    Seo KY; Chung SH; Lee JH; Park MY; Kim EK
    Cornea; 2007 Jul; 26(6):709-14. PubMed ID: 17592322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.
    Shukla SK; Gunda V; Abrego J; Haridas D; Mishra A; Souchek J; Chaika NV; Yu F; Sasson AR; Lazenby AJ; Batra SK; Singh PK
    Oncotarget; 2015 Aug; 6(22):19118-31. PubMed ID: 26046375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of human mucin gene MUC4 in pancreatic cancer cells.
    Zhang J; Zhang X; Zhu Y; Chen Z; Xu Z; Miao Y
    Mol Biol Rep; 2010 Jul; 37(6):2797-802. PubMed ID: 19757157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
    Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
    Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.
    Torres MP; Ponnusamy MP; Chakraborty S; Smith LM; Das S; Arafat HA; Batra SK
    Mol Cancer Ther; 2010 May; 9(5):1419-31. PubMed ID: 20423995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.